Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
88.24
-0.31 (-0.35%)
At close: Jun 15, 2026, 4:00 PM EDT
88.40
+0.16 (0.18%)
After-hours: Jun 15, 2026, 7:27 PM EDT
Celcuity Market Cap
Celcuity has a market cap or net worth of $4.3 billion as of June 15, 2026. Its market cap has increased by 969.10% in one year.
Market Cap
4.30B
Enterprise Value
4.24B
1-Year Change
969.10%
Ranking
Category
Stock Price
$88.24
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $4.30B, an increase of 3,113.69%. That is a compound annual growth rate of 48.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 4.30B | -6.76% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caris Life Sciences | 5.08B |
| Xenon Pharmaceuticals | 5.04B |
| Travere Therapeutics | 4.84B |
| CRISPR Therapeutics AG | 4.80B |
| Dianthus Therapeutics | 4.49B |
| Tango Therapeutics | 4.48B |
| Erasca | 4.37B |
| Oruka Therapeutics | 4.22B |